Perbedaan UBC Medical Indonesia Tbk. dan Logindo Samudramakmur Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb), sedangkan Logindo Samudramakmur Tbk. diperdagangkan di Rp108 (kapitalisasi pasar 655,36 M, volume 24 jam 15,22 jt). Perbedaan utamanya: UBC Medical Indonesia Tbk. dan Logindo Samudramakmur Tbk. berukuran mirip dari sisi kapitalisasi pasar, dan Logindo Samudramakmur Tbk. lebih aktif diperdagangkan (15,22 jt vs 843 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | LEAD | |
|---|---|---|
Kapitalisasi Pasar | 635,95 M | 655,36 M |
Volume | 843 rb | 15,22 jt |
Lot | 8,43 rb | 152,25 rb |
Perputaran | 137,6 jt | 1,67 M |
Harga Rata-rata | 163,22 | 109,39 |
Nilai Transaksi | 137,6 jt | 1,67 M |
Harga Ekuilibrium Indikatif | 165 | 108 |
Volume Ekuilibrium Indikatif | 246 | 1,95 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →PT Logindo Samudramakmur Tbk (the Company) is domiciled and was established in Jakarta, Indonesia based on Notarial Deed No. 55 of Nurul Hidajati Handoko, SH., Public Notary in Jakarta dated August 23, 1995. The company currently owns and operates a fleet of 58 offshore support with various types and functions. The company has a portfolio of customers ranging from mining oil and gas local to multinational.
Selengkapnya di halaman LEAD →